trend toward significanceP = 0.083
Chi-square and Fisher’s exact tests revealed no significant differences in CCR rate between CD30 status subgroups following end of RTSEI ( P = 0.24) or six weeks ( P = 0.44), but did trend toward significance at 6 months post-TSEI ( P = 0.083).